Pharma Focus Asia

Near infra red spectroscopy as a multivariate process analytical tool for predicting pharmaceutical co-crystal concentration

Authors: Clive Wooda, Abdolati Alwatia, Sheelagh Halseyb, Timothy Gougha, Elaine Browna, Adrian Kellya, Anant Paradkara

Abstract:

The use of near infra red spectroscopy to predict the concentration of two pharmaceutical co-crystals; 1:1 ibuprofen – nicotinamide (IBU-NIC) and 1:1 carbamazepine – nicotinamide (CBZ-NIC) has been evaluated. A Partial Least Squares (PLS) regression model was developed for both co-crystal pairs using sets of standard samples to create calibration and validation data sets with which to build and validate the models. Parameters such as the root mean square error of calibration (RMSEC), root mean square error of prediction (RMSEP) and correlation coefficient were used to assess the accuracy and linearity of the models. Accurate PLS regression models were created for both co-crystal pairs which can be used to predict the co-crystal concentration in a powder mixture of the co-crystal and the active pharmaceutical ingredient (API). The IBU-NIC model had smaller errors than the CBZ-NIC model, possibly due to the complex CBZ-NIC spectra which could reflect the different arrangement of hydrogen bonding associated with the co-crystal compared to the IBU-NIC co-crystal. These results suggest that NIR spectroscopy can be used as a PAT tool during a variety of pharmaceutical co-crystal manufacturing methods and the presented data will facilitate future offline and in-line NIR studies involving pharmaceutical co-crystals.

Keywords
Co-crystal; NIR spectroscopy; Partial Least Squares; Prediction; Active Pharmaceutical Ingredient; Process Analytical Tool

Citation: Clive  Wood,  Abdolati  Alwati,  Sheelagh  Halsey, Timothy Gough, Elaine Brown, Adrian Kelly, Anant Paradkar, Near infra red spectroscopy as a multivariate process analytical tool for predicting pharmaceutical co-crystal  concentration,  Journal  of  Pharmaceutical  and  Biomedical  Analysis http://dx.doi.org/10.1016/j.jpba.2016.06.010

Received: 11 March 2016, Revised: 5 June 2016, Accepted: 7 June 2016, Available: online 7 June 2016

Copyright: © 2016 Elsevier B.V. or its licensors or contributors.Open Access funded by Engineering and Physical Sciences Research Council.

Conclusion
The results demonstrate that NIR spectroscopy can be used to accurately distinguish between the individual components and the co-crystal form of two different pharmaceutical co-crystal pairs. Clear differences in the NIR spectra were observed when shown in the second derivative, and varying levels of chemometrics enabled the PLS regression to achieve relatively low calibration and validation error values. The findings suggest that NIR spectroscopy could be utilised as an accurate PAT tool for pharmaceutical co-crystal manufacturing methods and could aid understanding of the co-crystallisation process.

Acknowledgements
This work was funded by the Engineering and Physical Sciences Research Council, UK; grant code EP/J003360/1.

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024